Cibc Asset Management Inc Dexcom Inc Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Cibc Asset Management Inc holds 123,891 shares of DXCM stock, worth $9.92 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

123,891

Previous 116,249 6.57%

Holding current value

$9.92 Million

Previous $13.2 Million 37.0%

% of portfolio

0.03%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$64.0 - $116.06 $489,088 - $886,930	7,642 Added 6.57%	123,891 $8.3 Million
Q2 2024 Aug 01, 2024	BUY	$110.31 - $140.45 $280,297 - $356,883	2,541 Added 2.23%	116,249 $13.2 Million
Q1 2024 May 09, 2024	BUY	$114.22 - $140.1 $682,121 - $836,677	5,972 Added 5.54%	113,708 $15.8 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $15,475 - $25,452	-205 Reduced 0.19%	107,736 $13.4 Million
Q3 2023 Oct 30, 2023	BUY	$86.06 - $137.93 $933,234 - $1.5 Million	10,844 Added 11.17%	107,941 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $60,396 - $70,336	-537 Reduced 0.55%	97,097 $12.5 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $21,632 - $25,567	208 Added 0.21%	97,634 $11.3 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $96,282 - $138,985	-1,133 Reduced 1.15%	97,426 $11 Million
Q3 2022 Nov 03, 2022	BUY	$76.35 - $94.18 $504,215 - $621,964	6,604 Added 7.18%	98,559 $7.94 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $4.88 Million - $9.54 Million	71,780 Added 355.79%	91,955 $6.85 Million
Q1 2022 May 06, 2022	BUY	$94.08 - $130.2 $55,130 - $76,297	586 Added 2.99%	20,175 $10.3 Million
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $244,934 - $307,078	1,886 Added 10.65%	19,589 $10.5 Million
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $31,799 - $42,667	298 Added 1.71%	17,703 $9.68 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $61,714 - $82,242	762 Added 4.58%	17,405 $7.43 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $108,615 - $134,171	1,281 Added 8.34%	16,643 $5.98 Million
Q4 2020 Feb 03, 2021	BUY	$78.0 - $104.5 $79,872 - $107,008	1,024 Added 7.14%	15,362 $5.68 Million
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $75,643 - $89,456	792 Added 5.85%	14,338 $5.91 Million
Q2 2020 Jul 28, 2020	BUY	$62.68 - $105.34 $640,714 - $1.08 Million	10,222 Added 307.52%	13,546 $5.49 Million
Q1 2020 Apr 30, 2020	SELL	$47.79 - $75.63 $20,884 - $33,050	-437 Reduced 11.62%	3,324 $895,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $5,090 - $7,963	139 Added 3.84%	3,761 $823,000
Q3 2019 Oct 30, 2019	SELL	$35.53 - $43.8 $8,491 - $10,468	-239 Reduced 6.19%	3,622 $541,000
Q1 2019 May 06, 2019	BUY	$28.07 - $38.18 $18,975 - $25,809	676 Added 21.22%	3,861 $460,000
Q2 2018 Aug 09, 2018	BUY	$17.54 - $25.22 $3,736 - $5,371	213 Added 7.17%	3,185 $303,000
Q1 2018 Apr 30, 2018	BUY	$13.06 - $18.54 $38,814 - $55,100	2,972 New	2,972 $220,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Dexcom Inc Transaction History